Proximal Humeral Fracture
1
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Innovation PharmaceuticalsMA - Wakefield
1 program1
Locking proximal humerus platePhase 41 trial
Active Trials
ExactechFL - Gainesville
1 programExactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-upN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Innovation PharmaceuticalsLocking proximal humerus plate
ExactechExactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up
Clinical Trials (2)
Total enrollment: 791 patients across 2 trials
LPHP-Philos-PHN Conservative Treatment
Start: Aug 2002Est. completion: Aug 2006640 patients
Phase 4Completed
Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up
Start: Apr 2023Est. completion: Sep 2034151 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 791 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.